|
JPS4927290B1
(enExample)
|
1969-08-05 |
1974-07-16 |
|
|
|
US4071618A
(en)
|
1974-09-03 |
1978-01-31 |
Research Foundation For Microbial Diseases Of Osaka University |
Process for preparing virus disease live vaccines
|
|
JPS57136528A
(en)
|
1981-02-09 |
1982-08-23 |
Hayashibara Biochem Lab Inc |
Preparation of viral vaccine
|
|
NZ219515A
(en)
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
|
US5786199A
(en)
|
1989-08-28 |
1998-07-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5840520A
(en)
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
|
US5919676A
(en)
|
1993-06-24 |
1999-07-06 |
Advec, Inc. |
Adenoviral vector system comprising Cre-loxP recombination
|
|
JP3484215B2
(ja)
|
1994-01-27 |
2004-01-06 |
花王株式会社 |
チャイニーズハムスター卵巣細胞変異株
|
|
US5750394A
(en)
|
1994-05-20 |
1998-05-12 |
The Mount Sinai Medical Center |
Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
|
|
CA2149197A1
(en)
|
1994-06-17 |
1995-12-18 |
Irene Popiel |
Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
|
|
ATE257175T1
(de)
|
1994-07-18 |
2004-01-15 |
Conzelmann Karl Klaus Prof Dr |
Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
|
|
EP0700991A1
(en)
|
1994-09-12 |
1996-03-13 |
Bayer Corporation |
Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
|
|
US5716821A
(en)
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
|
EP0704533A1
(en)
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
|
|
WO1996010631A1
(en)
|
1994-09-30 |
1996-04-11 |
St. Jude Children's Research Hospital |
Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
|
|
WO1996010400A1
(en)
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
|
US6843996B1
(en)
|
1995-06-05 |
2005-01-18 |
Medimmune Vaccines, Inc. |
Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation
|
|
ATE181112T1
(de)
|
1995-08-09 |
1999-06-15 |
Schweiz Serum & Impfinst |
Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
|
|
US6037348A
(en)
|
1996-02-09 |
2000-03-14 |
Eli Lilly And Company |
Inhibition of viral replication
|
|
DE19612967A1
(de)
|
1996-04-01 |
1997-10-02 |
Behringwerke Ag |
Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
|
|
DE19612966B4
(de)
|
1996-04-01 |
2009-12-10 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
|
|
US5994526A
(en)
|
1996-06-21 |
1999-11-30 |
Plant Genetic Systems |
Gene expression in plants
|
|
CN101012454B
(zh)
|
1996-07-15 |
2011-11-16 |
美国政府健康及人类服务部 |
从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法
|
|
US6271011B1
(en)
|
1996-10-15 |
2001-08-07 |
The University Of Georgia Research Foundation, Inc. |
Pasteurella neuraminidase coding sequences and diagnostic methods
|
|
TW570803B
(en)
|
1997-04-09 |
2004-01-11 |
Duphar Int Res |
Influenza vaccine
|
|
AU7471098A
(en)
|
1997-04-30 |
1998-11-24 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
|
|
AU7797798A
(en)
|
1997-05-23 |
1998-12-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
|
|
ES2255181T3
(es)
|
1997-08-05 |
2006-06-16 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Antigeno inmunoprotector contra la gripe y su uso en vacunacion.
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US20020010143A1
(en)
|
1997-09-26 |
2002-01-24 |
Miguel S. Barbosa |
Compositions and methods for the treatment of human cytomegalovirus infection
|
|
KR100281676B1
(ko)
|
1997-11-29 |
2001-04-02 |
신동권 |
신규한독감생백신바이러스
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6270958B1
(en)
|
1998-10-29 |
2001-08-07 |
Washington University |
Detection of negative-strand RNA viruses
|
|
ATE332364T1
(de)
|
1999-02-22 |
2006-07-15 |
Transgene Sa |
Verfahren zur gewinnung von purifizierter virenzuammensetzung
|
|
EP1035209A1
(en)
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
|
EP2910629B1
(en)
|
1999-04-06 |
2018-09-19 |
Wisconsin Alumni Research Foundation |
Recombinant influenza viruses for vaccines and gene therapy
|
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
DE122008000056I1
(de)
|
1999-07-14 |
2009-04-09 |
Sinai School Medicine |
In vitro-rekonstitution von segmentierten negativstrang-rna-viren
|
|
EP1222299A1
(en)
|
1999-10-01 |
2002-07-17 |
Genovo, Incorporated |
Production of recombinant aav using adenovirus comprising aav rep/cap genes
|
|
US6686168B1
(en)
|
1999-11-04 |
2004-02-03 |
Zymogenetics, Inc. |
Cell surface display of proteins by recombinant host cells
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US20020009436A1
(en)
|
1999-12-30 |
2002-01-24 |
Doyle Ron J. |
Methods and compositions for inhibiting adhesion by microorganisms
|
|
AU2001236042B9
(en)
|
2000-03-03 |
2006-06-29 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
|
|
AU5533601A
(en)
|
2000-04-14 |
2001-10-30 |
Wisconsin Alumni Res Found |
Viruses comprising mutation ion channel protein
|
|
CN101580849B
(zh)
|
2000-04-28 |
2012-11-21 |
圣朱德儿童研究医院 |
用于产生感染性流感病毒的dna转染系统
|
|
US6358733B1
(en)
|
2000-05-19 |
2002-03-19 |
Apolife, Inc. |
Expression of heterologous multi-domain proteins in yeast
|
|
US20040241139A1
(en)
|
2000-07-20 |
2004-12-02 |
Gerd Hobom |
Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1201760A1
(en)
|
2000-10-30 |
2002-05-02 |
ARTEMIS Pharmaceuticals GmbH |
Influenza virus vector for human dendritic cells
|
|
ES2327719T3
(es)
|
2001-01-18 |
2009-11-03 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Complejos de proteina oligomerica recombinante con potencial inmunogenico mejorado.
|
|
EP1233059A1
(en)
|
2001-02-09 |
2002-08-21 |
ARTEMIS Pharmaceuticals GmbH |
Influenza viruses with enhanced transcriptional and replicational capacities
|
|
US7176021B2
(en)
|
2001-02-23 |
2007-02-13 |
Wisconsin Alumni Research Foundation |
Mutant cells with altered sialic acid
|
|
DE10144906B4
(de)
|
2001-09-12 |
2013-11-28 |
Novartis Vaccines And Diagnostics Gmbh |
Verfahren zur großtechnischen Herstellung von Impfstoffen
|
|
US7682618B2
(en)
|
2001-11-07 |
2010-03-23 |
The United States Of America As Represented By The Secretary Of The Army |
Generation of virus-like particles and use as panfilovirus vaccine
|
|
CA2465895C
(en)
|
2001-11-07 |
2012-10-02 |
U.S. Army Medical Research Institute Of Infectious Diseases Department Of The Army |
Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
|
|
US6951752B2
(en)
|
2001-12-10 |
2005-10-04 |
Bexter Healthcare S.A. |
Method for large scale production of virus antigen
|
|
US7211378B2
(en)
|
2002-01-31 |
2007-05-01 |
Wisconsin Alumni Research Foundation |
Filovirus vectors and noninfectious filovirus-based particles
|
|
CA2816242C
(en)
|
2002-02-13 |
2019-01-08 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
|
EP1572910B1
(en)
|
2002-02-13 |
2015-12-02 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
|
AU2002239151A1
(en)
|
2002-03-08 |
2003-09-22 |
Crucell Holland B.V. |
Use of recombinant trypsin for vaccine production
|
|
FR2837497A1
(fr)
|
2002-03-22 |
2003-09-26 |
Univ Nantes |
Procede de production de vecteurs lentiviraux a haut titre
|
|
DK1499348T3
(en)
|
2002-04-26 |
2015-01-05 |
Medimmune Llc |
PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE
|
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
US20060088909A1
(en)
|
2002-05-17 |
2006-04-27 |
Compans Richard W |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
EP2287288B1
(en)
|
2002-07-09 |
2012-11-07 |
Baxter International Inc. |
Animal protein free media for cultivation of cells
|
|
US6875433B2
(en)
|
2002-08-23 |
2005-04-05 |
The United States Of America As Represented By The Secretary Of The Army |
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
|
|
US20040242518A1
(en)
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US20040142322A1
(en)
|
2002-10-07 |
2004-07-22 |
Schering Corporation |
Continuous non-radioactive polymerase assay
|
|
CA2522081C
(en)
|
2003-04-23 |
2013-01-29 |
Wisconsin Alumni Research Foundation |
Recombinant influenza viruses holding a mutation in a transmembrane protein gene
|
|
CN1829799A
(zh)
|
2003-05-28 |
2006-09-06 |
威斯康星旧生研究基金会 |
含polii启动子和核酶的重组流感载体
|
|
KR100908757B1
(ko)
|
2003-05-28 |
2009-07-22 |
위스콘신 얼럼나이 리서어치 화운데이션 |
백신 및 유전자 요법을 위한 고 역가 재조합 인플루엔자바이러스
|
|
US7566458B2
(en)
|
2003-06-16 |
2009-07-28 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US20060240515A1
(en)
|
2003-07-21 |
2006-10-26 |
Dimitrov Dimiter S |
Soluble fragments of the SARS-CoV spike glycoprotein
|
|
US7037707B2
(en)
|
2003-09-04 |
2006-05-02 |
St. Jude Children's Research Hospital |
Method for generating influenza viruses and vaccines
|
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
|
ES2345492T3
(es)
|
2003-12-23 |
2010-09-24 |
Medimmune, Llc |
Sistema multiplasmido para la produccion del virus de la gripe.
|
|
JP2005245302A
(ja)
|
2004-03-04 |
2005-09-15 |
Kanazawa Univ Tlo Inc |
組換えインフルエンザウイルスおよびそれを用いたワクチン
|
|
US20060099609A1
(en)
|
2004-04-13 |
2006-05-11 |
Sina Bavari |
Activation of natural killer (NK) cells and methods of use
|
|
WO2005113758A1
(en)
|
2004-05-20 |
2005-12-01 |
Id Biomedical Corporation |
Process for the production of an influenza vaccine
|
|
ATE489965T1
(de)
|
2004-09-09 |
2010-12-15 |
Novartis Vaccines & Diagnostic |
Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
|
|
US20080292658A1
(en)
|
2004-11-11 |
2008-11-27 |
Emmie De Wit |
Defective Influenza Virus Particles
|
|
KR20070086344A
(ko)
|
2004-11-19 |
2007-08-27 |
위스콘신 얼럼나이 리서어치 화운데이션 |
탠덤 전사 유닛을 갖는 재조합 인플루엔자 벡터
|
|
US7670837B2
(en)
|
2004-12-23 |
2010-03-02 |
Medimmune, Llc |
Non-tumorigenic MDCK cell line for propagating viruses
|
|
BRPI0518568A2
(pt)
|
2004-12-24 |
2008-11-25 |
Solvay Pharm Bv |
mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico
|
|
EP1856271A4
(en)
|
2005-03-08 |
2009-11-18 |
Medimmune Vaccines Inc |
INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
|
|
EP1877088B1
(en)
|
2005-04-11 |
2014-12-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Vaccine against pandemic strains of influenza viruses
|
|
FR2887958B1
(fr)
|
2005-07-01 |
2007-10-12 |
Prospection Et D Inv S Techniq |
Dispositif de reglage de commande de vanne pour appareil de fixation a gaz et l'appareil comportant le dispositif
|
|
NL1030161C2
(nl)
|
2005-10-11 |
2007-04-12 |
Matthijs Dirk Meulenbelt |
Presentatie-inrichting.
|
|
US8354114B2
(en)
|
2005-10-17 |
2013-01-15 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
US20110027314A1
(en)
|
2006-01-27 |
2011-02-03 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
Influenza Vaccines Containing Hemagglutinin and Matrix Proteins
|
|
AU2012204138B2
(en)
|
2006-03-31 |
2014-02-06 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2014202470B2
(en)
|
2006-03-31 |
2016-08-04 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
EP2010557B1
(en)
|
2006-03-31 |
2014-02-26 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
US7883844B2
(en)
|
2006-05-11 |
2011-02-08 |
Juridical Foundation The Chemosero-Therapeutic Research Institute |
Method for propagating influenza virus
|
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
|
US7507411B2
(en)
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
|
EP2049662A4
(en)
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
|
|
AU2007286161B2
(en)
|
2006-08-09 |
2013-05-02 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
US20080286850A1
(en)
|
2006-09-15 |
2008-11-20 |
Medimmune Vaccines, Inc. |
Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
|
|
CN101553252A
(zh)
|
2006-12-06 |
2009-10-07 |
诺华有限公司 |
包含来自于四株流感病毒的抗原的疫苗
|
|
WO2009008921A2
(en)
|
2007-03-28 |
2009-01-15 |
Yoshihiro Kawaoka |
Influenza b viruses with reduced sensitivity to neuraminidase inhibitors
|
|
JP4880750B2
(ja)
|
2007-04-16 |
2012-02-22 |
ビ−エイイ− システムズ パブリック リミテッド カンパニ− |
腐食センサ
|
|
US8597661B2
(en)
|
2007-05-04 |
2013-12-03 |
Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
|
WO2008156681A2
(en)
|
2007-06-14 |
2008-12-24 |
Yoshihiro Kawaoka |
Adenoviral vectors for influenza virus production
|
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
|
CA2690196A1
(en)
|
2007-06-18 |
2008-12-24 |
Medimmune, Llc |
Influenza b viruses having alterations in the hemaglutinin polypeptide
|
|
WO2008155681A1
(en)
|
2007-06-21 |
2008-12-24 |
Nds Limited |
Power saving device
|
|
EP2048237A1
(en)
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
SG182957A1
(en)
|
2007-06-27 |
2012-08-30 |
Novartis Ag |
Low-additive influenza vaccines
|
|
WO2009014919A2
(en)
|
2007-07-13 |
2009-01-29 |
Iowa State University Research Foundation, Inc. |
H2n3 influenza a viruses and methods of use
|
|
EP2215231A4
(en)
|
2007-10-15 |
2010-12-01 |
Univ Queensland |
EXPRESSION SYSTEM FOR MODULATING AN IMMUNE RESPONSE
|
|
WO2009128867A2
(en)
|
2008-01-07 |
2009-10-22 |
Warf - Wisconsin Alumni Research Foundation |
Recombinant biologically contained filovirus
|
|
EP2296701A1
(en)
|
2008-06-11 |
2011-03-23 |
Flugen, Inc. |
Cell-based systems for producing influenza vaccines
|
|
BRPI0915487A2
(pt)
|
2008-07-11 |
2017-06-27 |
Medimmune Inc |
hemaglutina de nfluenza e variantes de neuraminidase
|
|
JP5852883B2
(ja)
|
2008-08-08 |
2016-02-03 |
タケダ ワクチン，インコーポレイテッド |
交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
|
|
WO2010053573A2
(en)
|
2008-11-07 |
2010-05-14 |
Yoshihiro Kawaoka |
Screen for inhibitors of filovirus and uses therefor
|
|
KR101548790B1
(ko)
|
2009-07-16 |
2015-08-31 |
크루셀 홀란드 비.브이. |
백신 제조를 위한 고역가 폴리오바이러스의 제조
|
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
|
EP2459585B1
(en)
|
2009-07-30 |
2024-09-04 |
Icahn School of Medicine at Mount Sinai |
Influenza viruses and uses thereof
|
|
US8507247B2
(en)
|
2009-08-11 |
2013-08-13 |
Wisconsin Alumni Research Foundation |
Influenza A virus with attenuating mutations in NS2 protein
|
|
US9109013B2
(en)
|
2009-10-26 |
2015-08-18 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in vero cells
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
KR101740019B1
(ko)
|
2009-11-10 |
2017-05-26 |
주식회사 팬택 |
무선통신시스템에서 시스템 정보 송수신 방법 및 그를 이용한 시스템 정보 송신장치와 수신장치
|
|
AU2010321710B2
(en)
|
2009-11-23 |
2013-03-07 |
Wm. Wrigley Jr. Company |
Gum bases, chewing gums based thereupon, and methods for making the same
|
|
WO2011087839A1
(en)
|
2009-12-22 |
2011-07-21 |
Baxter International Inc. |
Vaccine to influenza a virus
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
MX340735B
(es)
|
2010-04-09 |
2016-07-22 |
Univ Utrecht Holding Bv |
Proteinas multimericas recombinantes de la influenza.
|
|
EP2560680B1
(en)
|
2010-04-16 |
2018-11-28 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Chimpanzee adenoviral vector-based filovirus vaccines
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012033236A1
(ko)
|
2010-09-06 |
2012-03-15 |
에스케이케미칼 주식회사 |
무혈청 배양 및 부유 배양에 적응된 ｍｄｃｋ 세포주 및 상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
|
|
HUE027649T2
(en)
|
2010-10-07 |
2016-10-28 |
Ac Immune Sa |
Antibodies recognising phospho-tau
|
|
CN107267459A
(zh)
|
2011-01-06 |
2017-10-20 |
约翰·霍普金斯大学 |
在哺乳动物细胞中产生具有延长的循环半衰期的重组糖蛋白的方法
|
|
DK3447131T3
(da)
|
2011-06-24 |
2021-09-13 |
Flugen Inc |
Influenza a-virusmutanter
|
|
WO2013032942A1
(en)
|
2011-08-26 |
2013-03-07 |
Yoshihiro Kawaoka |
Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
|
|
CN102304495A
(zh)
|
2011-09-08 |
2012-01-04 |
中国农业科学院上海兽医研究所 |
高效表达ha蛋白的重组流感病毒及其制备方法和应用
|
|
AU2013205478B9
(en)
|
2012-03-02 |
2014-11-20 |
Seqirus UK Limited |
Influenza virus reassortment
|
|
JP2015527296A
(ja)
|
2012-03-26 |
2015-09-17 |
アメリカ合衆国 |
哺乳動物細胞へのパッケージングされたｒｎａの新規の送達
|
|
WO2014078674A1
(en)
|
2012-11-16 |
2014-05-22 |
Medimmune, Llc |
Swine influenza hemagglutinin and neuraminidase variants
|
|
JP6568514B2
(ja)
|
2013-03-15 |
2019-08-28 |
エーシー イミューン エス．エー． |
抗タウ抗体及び使用方法
|
|
CA2914604A1
(en)
|
2013-06-06 |
2014-12-11 |
Novartis Ag |
Influenza virus reassortment
|
|
EP3022296B1
(en)
|
2013-07-15 |
2022-12-28 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
|
CN106661569B
(zh)
|
2014-03-04 |
2020-09-11 |
西格马—奥尔德里奇有限责任公司 |
抗病毒细胞及其用途
|
|
WO2015142671A2
(en)
|
2014-03-17 |
2015-09-24 |
Flugen, Inc. |
Influenza virus vectors and uses therefor
|
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
WO2016034678A2
(en)
|
2014-09-03 |
2016-03-10 |
Bavarian Nordic A/S |
Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
|
|
CN106999566B
(zh)
|
2014-10-03 |
2022-01-28 |
麻省理工学院 |
结合埃博拉病毒糖蛋白的抗体及其用途
|
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
|
US10429386B2
(en)
|
2015-03-10 |
2019-10-01 |
The Regents Of The University Of California |
Antibodies to the surface of Toxoplasma gondii oocysts and methods of use thereof
|
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
|
HK1254344A1
(zh)
|
2015-06-26 |
2019-07-19 |
Seqirus UK Limited |
抗原匹配的流感疫苗
|
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
|
US20170121391A1
(en)
|
2015-07-07 |
2017-05-04 |
Wisconsin Alumni Research Foundation (Warf) |
Potent glycoprotein antibody as a therapeutic against ebola virus
|
|
JP2018530314A
(ja)
|
2015-08-28 |
2018-10-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ウイルス様粒子からの感染性インフルエンザウイルスの生成
|
|
CN105296356A
(zh)
|
2015-12-02 |
2016-02-03 |
河南农业大学 |
一种刚地弓形虫卵囊的制备、纯化及保存方法
|
|
US10063211B2
(en)
|
2016-02-03 |
2018-08-28 |
Qualcomm Incorporated |
Compact bypass and decoupling structure for millimeter-wave circuits
|
|
EP3417056A1
(en)
|
2016-02-19 |
2018-12-26 |
Wisconsin Alumni Research Foundation (WARF) |
Improved influenza b virus replication for vaccine development
|
|
JP2018064493A
(ja)
|
2016-10-19 |
2018-04-26 |
京都府公立大学法人 |
Ｍｄｃｋ細胞を用いたインフルエンザウイルスの増殖方法
|
|
JP2021500891A
(ja)
|
2017-10-25 |
2021-01-14 |
ウィスコンシン アルムニ リサーチ ファンデイション |
卵における複製のための安定化されたｈａを有する組換えインフルエンザウイルス
|
|
WO2019241579A1
(en)
|
2018-06-13 |
2019-12-19 |
Wisconsin Alumni Research Foundation |
Toxoplasma gondii vaccine
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
JP7655849B2
(ja)
|
2018-08-20 |
2025-04-02 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
|
|
CN113423421A
(zh)
|
2018-09-21 |
2021-09-21 |
内布拉斯加大学董事会 |
制备和使用通用中心化流感疫苗基因的方法
|
|
US11241492B2
(en)
|
2019-01-23 |
2022-02-08 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to genes in influenza viruses
|
|
EP3921413A1
(en)
|
2019-02-08 |
2021-12-15 |
Wisconsin Alumni Research Foundation (WARF) |
Humanized cell line
|
|
US11390649B2
(en)
|
2019-05-01 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
|
US20220249652A1
(en)
|
2019-06-26 |
2022-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus neuraminidase and uses thereof
|
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたｎａを有する組換えインフルエンザウイルス
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
US12290562B2
(en)
|
2020-03-25 |
2025-05-06 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
WO2021242597A1
(en)
|
2020-05-23 |
2021-12-02 |
Wisconsin Alumni Research Foundation ("Warf") |
Ace2 expressing influenza virus
|
|
WO2022245888A1
(en)
|
2021-05-19 |
2022-11-24 |
Modernatx, Inc. |
Seasonal flu rna vaccines and methods of use
|
|
US20230321217A1
(en)
|
2021-09-28 |
2023-10-12 |
Yoshihiro Kawaoka |
Compositions comprising complexes displaying antigens and methods of using the compositions
|
|
WO2023125889A1
(en)
|
2021-12-31 |
2023-07-06 |
Suzhou Abogen Biosciences Co., Ltd. |
Quadrivalent mrna vaccines for influenza viruses
|
|
WO2023164556A2
(en)
|
2022-02-23 |
2023-08-31 |
Wisconsin Alumni Research Foundation |
Broadly protective influenza b virus vaccines
|
|
WO2024015510A1
(en)
|
2022-07-13 |
2024-01-18 |
Wisconsin Alumni Research Foundation ("Warf") |
Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-19
|
|
US20240238403A1
(en)
|
2022-11-16 |
2024-07-18 |
Wisconsin Alumni Research Foundation |
Influenza virus replication for vaccine development
|
|
WO2024197167A1
(en)
|
2023-03-21 |
2024-09-26 |
Wisconsin Alumni Research Foundation |
A cold-adapted, live attenuated sars-cov-2 vaccine
|